Stefan Krauss received 9 mio NOK (900.000 EUR) from the South-Eastern Norway Regional Health Authority (HSØ) for the project entitled Virus induced Acute Respiratory Distress Syndrome (ARDS): Testing pathway inhibitors on a Lung-on–a-Chip platform. The central aim of this project is to provide proof of concept models, applying innovative Lung-on-a-Chip technology, to test therapeutic interventions on virus induced ARDS.
